Jiaoze
+86-21-37318802
[email protected]
Sitemap |  RSS |  XML
English English
  • English English
  • Home
  • About Us
    • Company Profile
    • Development History
    • Corporate Culture
  • Products
    • Intermediates And APIs
      • Intermediate
      • Active Pharmaceutical Ingredient
    • Veterinary Drug Service
    • Cosmetics Ingredients
  • News
    • Industry News
    • Company News
  • R&D Services
  • Send Inquiry
  • Contact Us
Home Links

Product Categories

  • Intermediates And APIs

    • Intermediate
    • Active Pharmaceutical Ingredient
  • Veterinary Drug Service

  • Cosmetics Ingredients

New Products
  • Shikimic Acid CAS 138-59-0
    Shikimic Acid CAS 138-59-0
  • (R)-3-Piperidinamine dihydrochloride CAS 334618-23-4
    (R)-3-Piperidinamine dihydrochloride CAS 334618-23-4
  • Creatine monohydrate CAS 6020-87-7
    Creatine monohydrate CAS 6020-87-7
  • Tetramethyluric acid CAS 2309-49-1 HPLC 60%
    Tetramethyluric acid CAS 2309-49-1 HPLC 60%
  • Berberine hydrochloride CAS 633-65-8
    Berberine hydrochloride CAS 633-65-8
All new products
Links
Links:

    Contact Us

    • Address: No.688 Qiushi Road, Jinshan Wei Town, Shanghai, China
    • Phone: +86-21-37318802
    • E-mail: [email protected]

    Inquiry For Price list

    For inquiries about our products or pricelist, please leave your email to us and we will be in touch within 24 hours.

    Latest News

    • The Rapid Growth of the Global Small Molecule CDMO Market: Driving Innovation and Efficiency in Drug Development
      The Rapid Growth of the Global Small Molecule CDMO Market: Driving Innovation and Efficiency in Drug Development 2025/11/28

      The global Small Molecule CDMO market is experiencing unprecedented growth as pharmaceutical and biotechnology companies increasingly rely on external expertise to accelerate drug development and production. With the growing complexity of modern therapeutics and the rising demand for high-quality, cost-efficient manufacturing solutions, CDMOs have become integral partners in the global pharmaceutical supply chain.

    • The Growing Importance of CDMO Small Molecule Drug Services in Advancing Global Pharmaceutical Innovation
      The Growing Importance of CDMO Small Molecule Drug Services in Advancing Global Pharmaceutical Innovation 2025/11/25

      The importance of CDMO Small Molecule Drug Services lies in their ability to bridge the gap between discovery and large-scale production. Developing a new drug is a complex, time-consuming, and costly process that involves multiple stages — from molecular design and synthesis to clinical trials and regulatory approval. CDMOs offer specialized support at each step, allowing pharmaceutical and biotechnology companies to focus on innovation while outsourcing complex manufacturing and compliance operations to trusted experts.

    Copyright © 2024 Shanghai Jiaoze Industrial Co., Ltd. - All Rights Reserved
    • Links
    • Sitemap
    • RSS
    • XML
    • Jiaoze Industrial
    • Jiaoze Industrial
    • Jiaoze Industrial
    • Jiaoze Industrial
    • Jiaoze Industrial